Key Insights

Highlights

Treatment Research

3 treatments under study, led by Mri 7t

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03039166Not ApplicableUnknownPrimary

Metabolic and Structural Characterization of Hub's Vulnerability in Neurological Diseases Assessed by Ultra High Field Structural and Functional MRI

Showing all 1 trials

Research Network

Common Treatments

  • Mri 7t1
  • Blood Sample1
  • Mri 3 T1

Active Sponsors

  • Assistance Publique Hopitaux De Marseille1

Top Investigators

Activity Timeline